New tool aims to better measure psoriasis burden over a lifetime
NCT ID NCT05959070
First seen Apr 01, 2026 · Last updated May 19, 2026 · Updated 6 times
Summary
This study tested a new questionnaire called DermCLCI-p to see if it accurately measures the long-term life impacts of moderate-to-severe psoriasis. 154 adults starting a standard treatment (risankizumab) filled out the questionnaire over 28 weeks. The goal was to validate the tool, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cliniques Universitaires UCL Saint-Luc /ID# 253234
Brussels, Brussels Capital, 1200, Belgium
-
Dermatologie Maldegem /ID# 252454
Maldegem, Oost-Vlaanderen, 9990, Belgium
-
Dermatologische Praxis Dr. med. Marvin Kuske /ID# 265688
Dresden, 01109, Germany
-
Dermatrials Research /ID# 253879
Hamilton, Ontario, L8N 1Y2, Canada
-
Dre Angelique Gagne-Henley M.D. inc. /ID# 262591
Saint-Jérôme, Quebec, J7Z 7E2, Canada
-
Gemeinschaftspraxis Dres. Anika Hünermund/Mario Pawlak /ID# 255874
Heilbad Heiligenstadt, 37308, Germany
-
Hautarztpraxis Mortazawi /ID# 255872
Remscheid, North Rhine-Westphalia, 42897, Germany
-
JRB Research /ID# 253877
Ottawa, Ontario, K1H 7X3, Canada
-
Lynde Institute for Dermatology /ID# 253876
Markham, Ontario, L3P 1X2, Canada
-
Praxis Dres. Wiemers/Wiemers /ID# 255873
Leipzig, 04317, Germany
-
SKiN Centre for Dermatology /ID# 255882
Peterborough, Ontario, K9J 5K2, Canada
-
UZ Gent /ID# 252458
Ghent, Oost-Vlaanderen, 9000, Belgium
-
Universitaetsklinikum Hamburg-Eppendorf /ID# 254340
Hamburg, 20246, Germany
-
Universitair Ziekenhuis Leuven /ID# 252457
Leuven, Vlaams-Brabant, 3000, Belgium
-
Universite Libre de Bruxelles - Hopital Erasme /ID# 252456
Anderlecht, Brussels Capital, 1070, Belgium
-
Wiseman Dermatology Research /ID# 255883
Winnipeg, Manitoba, R3M 3Z4, Canada
Conditions
Explore the condition pages connected to this study.